Advertisement
Screener

Monopar Therapeutics Inc. (MNPR) Form D

Monopar Therapeutics Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2017-08-23: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale Yet to occur; Total offering amount $4,500,000.
  • 2017-03-28: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale Yet to occur; Total offering amount $10,000,000.
  • 2016-03-15: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale Yet to occur; Total offering amount $3,000,000.
  • 2015-06-18: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-06-10; Total offering amount $6,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2017-08-23Rule 506(b)EquityYet to occur$4,500,000$0$4,500,0000
2017-03-28Rule 506(b)EquityYet to occur$10,000,000$0$10,000,0000
2016-03-15Rule 506(b)EquityYet to occur$3,000,000$0$3,000,0000
2015-06-18Rule 506(b)Equity2015-06-10$6,000,000$2,105,100$3,894,9008

Similar stocks

Stock NameCountryMarket CapPE Ratio
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Altimmune, Inc. (ALT)United States$0.593B-6.43
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Indaptus Therapeutics, Inc. (INDP)United States$0.537B